This consultation closes on Tuesday, 23 March 2021.

The Therapeutic Goods Administration (TGA) is conducting a public consultation that seeks to understand potential obstacles and incentives to repurposing of prescription medicines that may influence a sponsor's decision to extend an indication for an existing medicine. This will assist in identifying potential regulatory and reimbursement policy options and further consultation may occur.

To participate, please visit consultation hub .

Timetable

The consultation opens on Thursday, 4 February 2021.

Interested parties should respond by close of business Tuesday, 23 March 2021.

Enquiries

Any questions relating to submissions should be emailed to medicines.review@health.gov.au